FUNCTIONAL MAGNETIC STIMULATION – A NEW PROMISING TREATMENT METHOD FOR WOMEN WITH URINARY INCONTINENCE
Abstract
Background. For urinary incontinence there are different treatment options available and among them we are in favor of those, which are the least aggressive and are similarly efficient at the same time. In the last decade there has been an increasing body of evidence suggesting that the functional magnetic stimulation (FMS) might be a new and promising treatment modality for treating of women with urinary incontinence. FMS has been applied to pelvic floor therapy and the treatment of urinary incontinence for the first time in 1999. Contrary to electrical stimulation, FMS aims to stimulate the pelvic floor muscles without insertion of a vaginal probe. During the treatment patient is positioned in a special chair. Under the seat is a magnetic field generator which is producing a pulsating magnetic field which is penetrating the perineum. Structures such as pudendal nerves can therefore be magnetically stimulated without patient’s discomfort or inconvenience of probe insertion as it may be true for electrical stimulation. One of the drawbacks of FMS with magnetic chair is the need for repeated office-based treatment, what may represent a major burden for patients and also for national healthcare system. Therefore we developed a new small magnetic stimulator producing electromagnetic pulses which penetrate either the perineum or pubic bone and thus stimulate the pelvic floor and detrusor muscle. One of advantages of this small portable stimulator apart of its clinical eficacy is a continuous 24-hours stimulation which can be performed either at home/work or during different activities.
Conclusions. In this article we are presenting the literature overview regarding magnetic stimulation including our initial experiencies with this new treatment method. Based on our clinical results we feel that FMS represents a new and noninvasive treatment method for urinary incontinence.
Downloads
References
Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U et
al. The standardization of terminology of lower urinary tract
function: report from the standarisation sub-committee of the
international continence society. Neurourol Urodyn 2002; 21:
–78.
Hunskaar S, Lose G, Sykes D, Voss S. The prevalence of urinary
incontinence in women in four European contries. BJU International
; 93: 324–30.
Appel RA. Clinical efficacy and safety of tolterodine in the treatment
of overactive bladder: a pooled analysis. Urology 1997; 50:
–6.
Nabi G, Cody JD, Ellis G, Herbison P, Hay-Smith J. Anticholinergic
drugs versus placebo for overactive bladder syndrome in adults.
Cochrane Database Syst Rev 2006: CD003781.
Sand PK, Richardson DR, Staskin SE, Swift SE, Appell RA, Whitmore
KE, et al. Pelvic floor stimulation in the treatment of
genuine stress incontinence: a multicenter placebo-controlled
trial. Am J Obstet Gynecol 1995; 173: 72–9.
Siegel SW, Richardson DA, Miller KL, Karram MM, Blackwood
NB, Sand PK, et al. Pelvic floor electrical stimulation for the
treatment of urge and mixed urinary incontinence in women.
Urology 1997; 50: 934–40.
Kralj B. Conservative teatment of female stress urinary incontinence
with functional electrical stimulation. Eur J Obstet
Gynecol Reprod Biol 1999; 85: 53–6.
Yamanishi T, Yasuda K, Sakakibara R, Hattori T, Suda S. Randomized,
double-blind study of electrical stimulation for urinary
incontinence due to detrusor overactivity. Urology 2000; 55:
–7.
Galloway NT, El-Galley RE, Sand PK, Appell RA, Russell HW,
Carlan SJ. Extracorporeal magnetic innervation therapy for stress
urinary incontinence. Urology 1999; 53: 1108–11.
Yamanishi T, Yasuda K, Suda S, Ishikawa N. Effect of functional
continuous magnetic stimulation on urethral closure in healthy
volunteers. Urology 1999; 54: 652–5.
Yamanishi T, Sakakibaba R, Uchiyama T, Suda S, Hattori T, Ito H,
et al. Comparative study of the effects of magnetic versus electrical
stimulation on inhibition of detrusor overactivity. Urology
; 56: 777–81.
Galloway NT, El-Galley RE, Sand PK, Appell RA, Russell HW,
Carlin SJ. Update on extracorporeal magnetic innervation (ExMI)
therapy for stress urinary incontinence. Urology 2000; 56:
–6.
But I. Functional magnetic stimulation for treatment of urinary
incontinence – presentation of Pulsegen device. In: Kramer
G, ed. Proceedings, 32nd Annual Meeting of the International
Continence Society; Heidelberg; 28–30 August Heidelberg:
International continence society; 2002. p. 294.
But I. Conservative treatment of female urinary incontinence
with functional magnetic stimulation. Urology 2003; 61: 558–
But I, Faganelj M, Šoštarič A. Functional magnetic stimulation
for mixed urinary incontinence. J Urol 2005; 173: 1644–6.
Suzuki T, Yasuda K, Yamanishi T, Kitahara S, Nakai H, Suda S,
et al. Randomized, double-blind, sham-controlled evaluation
of the effect of functional continuous magnetic stimulation in
patients with urgency incontinence. Neurourol Urodyn 2007;
: 767–72.
Voorham-van der Zalm PJ, Pelger RC, Stiggelbout AM, Elzevier
HW, Lycklama à Nijeholt GA. Effects of magnetic stimulation
in the treatment of pelvic floor dysfunction. BJU Int 2006; 97:
–8.
Gilling PJ, Wilson LC, Westenberg AM, McAllister WJ, Kennett
KM, Frampton CM, at al. A double-blind randomized controlled
trial of electromagnetic stimulation of the pelvic floor vs sham
therapy in the treatment of women with stress urinary incontinence.
BJU Int 2009; 103: 1386–90.
But I, Varda NM. Functional magnetic stimulation: A new method
for the treatment of girls with primary nocturnal enuresis? J
Pediatr Urol 2006; 2: 415–8.
The Author transfers to the Publisher (Zdravniški vestnik/Slovenian Medical Journal) all economic copyrights following form Article 22 of the Slovene Copyright and Related Rights Act (ZASP), including the right of reproduction, the right of distribution, the rental right, the right of public performance, the right of public transmission, the right of public communication by means of phonograms and videograms, the right of public presentation, the right of broadcasting, the right of rebroadcasting, the right of secondary broadcasting, the right of communication to the public, the right of transformation, the right of audiovisual adaptation and all other rights of the author according to ZASP.
The aforementioned rights are transferred non-exclusively, for an unlimited number of editions, for the term of the statutory
The Author can make use of his work himself or transfer subjective rights to others only after 3 months from date of first publishing in the journal Zdravniški vestnik/Slovenian Medical Journal.
The Publisher (Zdravniški vestnik/Slovenian Medical Journal) has the right to transfer the rights, acquired parties without explicit consent of the Author.
The Author consents that the Article be published under the Creative Commons BY-NC 4.0 (attribution-non-commercial) or comparable licence.
